Jing Jiang1, You-Jin Zhao1, Xin-Yu Hu1, Ming-Ying Du1, Zi-Qi Chen1, Min Wu1, Kai-Ming Li1, Hong-Yan Zhu1, Poornima Kumar1, Qi-Yong Gong1. 1. From the Huaxi MR Research Center (HMRRC), Department of Radiology, Psychoradiology and Psychiatry, West China Hospital and Schools of Clinical Medicine, Sichuan University, Chengdu, China (Jiang, Zhao, Hu, Du, Chen, Wu, Li, Zhu, Gong); the Laboratory of Stem Cell Biology, State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China (Zhu); the Center for Depression, Anxiety and Stress Research, McLean Hospital, Belmont, Mass., USA (Kumar); Department of Psychiatry, Harvard Medical School, Boston, Mass., USA (Kumar); the Department of Psychiatry, Yale University School of Medicine, New Haven, Conn., USA (Gong).
Abstract
BACKGROUND: Multiple meta-analyses of diffusion tensor imaging (DTI) studies have reported impaired white matter integrity in patients with major depressive disorder (MDD). However, owing to inclusion of medicated patients in these studies, it is difficult to conclude whether these reported alterations are associated with MDD or confounded by medication effects. A meta-analysis of DTI studies on medication-free (medication-naive and medication washout) patients with MDD would therefore be necessary to disentangle MDD-specific effects. METHODS: We analyzed white matter alterations between medication-free patients with MDD and healthy controls using anisotropic effect size-signed differential mapping (AES-SDM). We used DTI query software for fibre tracking. RESULTS: Both pooled and subgroup meta-analyses in medication washout patients showed robust fractional anisotropy (FA) reductions in white matter of the right cerebellum hemispheric lobule, body of the corpus callosum (CC) and bilateral superior longitudinal fasciculus III (SLF III), whereas FA reductions in the genu of the CC and right anterior thalamic projections were seen in only medication-naive patients. Fibre tracking showed that the main tracts with observed FA reductions included the right cerebellar tracts, body of the CC, bilateral SLF III and arcuate fascicle. LIMITATIONS: The analytic techniques, patient characteristics and clinical variables of the included studies were heterogeneous; we could not exclude the effects of nondrug therapies owing to a lack of data. CONCLUSION: By excluding the confounding influences of current medication status, findings from the present study may provide a better understanding of the underlying neuropathology of MDD.
BACKGROUND: Multiple meta-analyses of diffusion tensor imaging (DTI) studies have reported impaired white matter integrity in patients with major depressive disorder (MDD). However, owing to inclusion of medicated patients in these studies, it is difficult to conclude whether these reported alterations are associated with MDD or confounded by medication effects. A meta-analysis of DTI studies on medication-free (medication-naive and medication washout) patients with MDD would therefore be necessary to disentangle MDD-specific effects. METHODS: We analyzed white matter alterations between medication-free patients with MDD and healthy controls using anisotropic effect size-signed differential mapping (AES-SDM). We used DTI query software for fibre tracking. RESULTS: Both pooled and subgroup meta-analyses in medication washout patients showed robust fractional anisotropy (FA) reductions in white matter of the right cerebellum hemispheric lobule, body of the corpus callosum (CC) and bilateral superior longitudinal fasciculus III (SLF III), whereas FA reductions in the genu of the CC and right anterior thalamic projections were seen in only medication-naive patients. Fibre tracking showed that the main tracts with observed FA reductions included the right cerebellar tracts, body of the CC, bilateral SLF III and arcuate fascicle. LIMITATIONS: The analytic techniques, patient characteristics and clinical variables of the included studies were heterogeneous; we could not exclude the effects of nondrug therapies owing to a lack of data. CONCLUSION: By excluding the confounding influences of current medication status, findings from the present study may provide a better understanding of the underlying neuropathology of MDD.
Authors: George S Alexopoulos; Charles E Glatt; Matthew J Hoptman; Dora Kanellopoulos; Christopher F Murphy; Robert E Kelly; Sarah S Morimoto; Kelvin O Lim; Faith M Gunning Journal: J Affect Disord Date: 2010-03-25 Impact factor: 4.839
Authors: K Matsuo; D C Glahn; M A M Peluso; J P Hatch; E S Monkul; P Najt; M Sanches; F Zamarripa; J Li; J L Lancaster; P T Fox; J-H Gao; J C Soares Journal: Mol Psychiatry Date: 2006-09-19 Impact factor: 15.992
Authors: Paul E Sijens; Jop P Mostert; Roy Irwan; Jan Hendrik Potze; Matthijs Oudkerk; Jacques De Keyser Journal: Psychiatry Res Date: 2008-12-30 Impact factor: 3.222
Authors: Robert K McNamara; Ruth H Asch; Diana M Lindquist; Robert Krikorian Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2017-05-09 Impact factor: 4.006
Authors: Victoria M Lawlor; Christian A Webb; Thomas V Wiecki; Michael J Frank; Madhukar Trivedi; Diego A Pizzagalli; Daniel G Dillon Journal: Psychol Med Date: 2019-07-08 Impact factor: 7.723
Authors: Xin Gao; Wenjing Zhang; Li Yao; Yuan Xiao; Lu Liu; Jieke Liu; Siyi Li; Bo Tao; Chandan Shah; Qiyong Gong; John A Sweeney; Su Lui Journal: J Psychiatry Neurosci Date: 2018-03 Impact factor: 6.186
Authors: Benjamin T Newman; Thijs Dhollander; Kristen A Reynier; Matthew B Panzer; T Jason Druzgal Journal: Magn Reson Med Date: 2020-02-28 Impact factor: 4.668